相关实验视频
Updated: May 5, 2026

06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
37.8K
揭开隐藏的催化剂:感染如何引发阿尔茨海默病
Tamas Fulop1,2, Alan A Cohen3,4, Eric H Frost5
1Department of Medicine, Division of Geriatrics, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada.
Journal of Alzheimer's disease : JAD
|January 27, 2026
概括
对于阿尔茨海默病 (AD) 的粉样蛋白假说已经产生了有限的治疗成功. 新出现的证据表明,慢性感染引发神经炎症和粉样蛋白-β (Aβ) 积累,为AD提供了新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 传染性疾病 传染性疾病
背景情况:
- 粉样蛋白假设长期以来一直主导着阿尔茨海默病 (AD) 研究和治疗开发.
- 目前针对粉样β (Aβ) 的AD疗法已显示出有限的临床疗效.
- 阿尔茨海默病是一种复杂的多因素疾病,具有很长的临床前发展期.
研究的目的:
- 审查支持阿尔茨海默病感染假设的证据.
- 探索慢性感染如何导致神经炎症和AD中的Aβ积累.
- 讨论感染假设的障碍及其在AD药物开发和治疗中的潜在整合.
主要方法:
- 对调查感染和AD病理之间的联系的研究进行文献综述.
- 分析慢性感染可能导致神经炎症和Aβ沉积的机制.
- 关于AD病因学的历史和当前观点的讨论.
主要成果:
- 慢性感染可以启动神经炎症,这是AD病变发生的关键因素.
- 感染为AD中观察到的Aβ和tau病理提供了一个合理的机制.
- 粉样蛋白为中心的方法面临着重大挑战,需要替代假设.
结论:
- 感染假设为理解和治疗AD提供了一个有希望的替代框架.
- 克服对感染假设的耐药性对于推动AD研究至关重要.
- 整合感染假设可以彻底改变AD诊断和治疗策略,提供新的希望.
相关概念视频
Amyloid Fibrils
10.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
10.3K
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Alzheimer Disease l: Introduction
29
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
29
Alzheimer Disease ll: Pathophysiology
42
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
42
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35

